Abstract
Obsessive-compulsive disorder is a frequent psychiatric disease, with neurobiological and psychological factors contributing to its genesis. The drugs of choice in somatic treatment of obsessive-compulsive patients are serotonin reuptake inhibitors, whereas behaviour therapy is the preferred psychotherapeutic approach. A combination of behaviour therapy with serotonin reuptake inhibitors is indicated in case of predominance of obsessions and if depressions are present. Following successful combined treatment, behaviour therapy appears to exert an additional protective effect against relapse.
| Translated title of the contribution | Differential indication in the treatment of obsessive-compulsive disorder |
|---|---|
| Original language | German |
| Journal | Psycho |
| Volume | 25 |
| Issue number | 7 |
| Pages (from-to) | 455-457 |
| Number of pages | 3 |
| ISSN | 0340-7845 |
| Publication status | Published - 1999 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 10 Reduced Inequalities
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Differential indication in the treatment of obsessive-compulsive disorder'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver